SCIENTIFIC HUB

Follow the evidence.

15.468 articles found

Open access

A designed ankyrin-repeat protein that targets Parkinson's disease-associated LRRK2.

Dederer V, Sanz Murillo M, Karasmanis EP, Hatch KS, Chatterjee D, Preuss F, Abdul Azeez KR, Nguyen LV, Galicia C, Dreier B, Plückthun A, Versees W, Mathea S, Leschziner AE, Reck-Peterson SL, Knapp S.

J Biol Chem · 2024-06-12

DOI: 10.1016/j.jbc.2024.107469PMID: 38876305

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Endogenous LRRK2 and PINK1 function in a convergent neuroprotective ciliogenesis pathway in the brain

Bagnoli E, Lin Y, Burel S, Jaimon E, Antico O, Themistokleous C, Nikoloff JM, Morella I, Watzlawik JO, Fiesel FC, Springer W, Tonelli F, Brooks SP, Dunnett SB, Brambilla R, Alessi DR, Pfeffer SR, Muqit MMK.

· 2024-06-11

DOI: 10.1101/2024.06.11.598416

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Open access

Single molecule array measures of LRRK2 kinase activity in serum link Parkinson's disease severity to peripheral inflammation.

Yuan Y, Li H, Sreeram K, Malankhanova T, Boddu R, Strader S, Chang A, Bryant N, Yacoubian TA, Standaert DG, Erb M, Moore DJ, Sanders LH, Lutz MW, Velmeshev D, West AB.

Mol Neurodegener · 2024-06-11

DOI: 10.1186/s13024-024-00738-4PMID: 38862989

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.